Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Methamphetamine Use During Pregnancy Maternal and Neonatal Implications

Methamphetamine Use During Pregnancy Maternal and Neonatal Implications Methamphetamine Use During Pregnancy Maternal and Neonatal Implications Meadow M. Good, DO, Ido Solt, MD, Joann G. Acuna, MD, Siegfried Rotmensch, MD, and Matthew J. Kim, MD OBJECTIVE: To report the demographic characteristics population. Because the patients in this study were in a and clinical morbidity of methamphetamine-exposed variety of ways demographically distinct, attempts to pregnancies compared with control patients in a tertiary identify these patients early and intervene in an effort to care, urban, academic medical center. improve pregnancy-related outcomes appears possible and warranted. METHODS: A single-site chart review from 2000 to 2006 (Obstet Gynecol 2010;116:330–4) was conducted. International Classification of Diseases, 9th Revision code 648.3x was used to identify potential LEVEL OF EVIDENCE: II study participants. Specific inclusion criteria required either a positive urine drug screen for methamphetamine ethamphetamine dependence is an escalating use or by patient statement of methamphetamine use Mproblem across the United States. Methamphet- during pregnancy. Data from 276 identified patients were then compared with the 34,055 in the general obstetric amine (N-methyl-1-phenyl-propan-2-amine) is the only population during the same period for various demo- illegal drug that can be easily made from legally ob- graphic factors and perinatal outcomes. tained ingredients, in particular over-the-counter http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Obstetrics & Gynecology Wolters Kluwer Health

Methamphetamine Use During Pregnancy Maternal and Neonatal Implications

Obstetrics & Gynecology , Volume 116 – Aug 1, 2010

Loading next page...
 
/lp/wolters-kluwer-health/methamphetamine-use-during-pregnancy-maternal-and-neonatal-t4yIL5qtia

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0029-7844
eISSN
1873-233X
DOI
10.1097/AOG.0b013e3181e67094
pmid
20664393
Publisher site
See Article on Publisher Site

Abstract

Methamphetamine Use During Pregnancy Maternal and Neonatal Implications Meadow M. Good, DO, Ido Solt, MD, Joann G. Acuna, MD, Siegfried Rotmensch, MD, and Matthew J. Kim, MD OBJECTIVE: To report the demographic characteristics population. Because the patients in this study were in a and clinical morbidity of methamphetamine-exposed variety of ways demographically distinct, attempts to pregnancies compared with control patients in a tertiary identify these patients early and intervene in an effort to care, urban, academic medical center. improve pregnancy-related outcomes appears possible and warranted. METHODS: A single-site chart review from 2000 to 2006 (Obstet Gynecol 2010;116:330–4) was conducted. International Classification of Diseases, 9th Revision code 648.3x was used to identify potential LEVEL OF EVIDENCE: II study participants. Specific inclusion criteria required either a positive urine drug screen for methamphetamine ethamphetamine dependence is an escalating use or by patient statement of methamphetamine use Mproblem across the United States. Methamphet- during pregnancy. Data from 276 identified patients were then compared with the 34,055 in the general obstetric amine (N-methyl-1-phenyl-propan-2-amine) is the only population during the same period for various demo- illegal drug that can be easily made from legally ob- graphic factors and perinatal outcomes. tained ingredients, in particular over-the-counter

Journal

Obstetrics & GynecologyWolters Kluwer Health

Published: Aug 1, 2010

There are no references for this article.